John Scott Cameron
4Patents
1h-index
13Co-inventors
37Inventor score
Filing activity: May 3, 2013 → Feb 8, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10561653B2 | 5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer | Chemistry; Metallurgy | 9 | Active |
| US11078191B2 | 1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use thereof in the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US11001628B2 | Combined use of anti PD-1 and anti M-CSF antibodies in the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US9353419B2 | Biomarkers for IAP inhibitor therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.